Oxybutynin-d5 hydrochloride
Oxybutynin-d5 hydrochloride is the d5-labeled (R)-Oxybutynin hydrochloride (HY-B0267B). (R)-Oxybutynin hydrochloride (Aroxybutynin hydrochloride), an enantiomer of Oxybutynin hydrochloride, is an orally active muscarinic receptor antagonist. (R)-Oxybutynin hydrochloride exhibits antispasmodic and anticholinergic activities, and competitively antagonizes carbachol-induced contractions. (R)-Oxybutynin hydrochloride can be used in the research of urinary incontinence caused by neurogenic bladder dysfunction.
For research use only. We do not sell to patients.
- Formula: C22H27D5ClNO3
- Molecular Weight:398.98
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
Biological Activity
Description
Application
1. This compound can be used as a tracer
2. This compound can be used as an internal standard for quantitative analysis by NMR, GC-MS, or LC-MS.
Chemical Information
-
Unlabeled CAS 1207344-05-5
-
Molecular Weight 398.98
-
Formula C22H27D5ClNO3
-
SMILES
O=C([C@](C1CCCCC1)(O)C2=CC=CC=C2)OCC#CCN(CC)C([2H])(C([2H])([2H])[2H])[2H].Cl
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Smith ER, et al. Comparison of the antimuscarinic and antispasmodic actions of racemic oxybutynin and desethyloxybutynin and their enantiomers with those of racemic terodiline. Arzneimittel-Forschung. 1998 Oct;48(10):1012-8. [Content Brief]
[2]. Zobrist RH, et al. Pharmacokinetics of the R- and S-enantiomers of oxybutynin and N-desethyloxybutynin following oral and transdermal administration of the racemate in healthy volunteers. Pharmaceutical research. 2001 Jul;18(7):1029-34. [Content Brief]
[4]. Siddiqui MA, et al. Oxybutynin extended-release: a review of its use in the management of overactive bladder. Drugs. 2004;64(8):885-912. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Oxybutynin-d5 hydrochloride Related Classifications
HY-B0267BS Related Classifications
Powered by Bioz
Keywords
- Oxybutynin-d5
- Isotope-Labeled Compounds
- mAChR
- M2 muscarinic receptor subtype
- smooth muscle relaxant
- neurogenic detrusor overactivity
- hypoglossal motor nucleus
- urinary incontinence
- muscarinic receptors
- M1 muscarinic receptor subtype
- overactive bladder
- muscarinic receptor antagonist
- obstructive sleep apnea
- Inhibitor
- inhibitor
- inhibit